Skip to main content

Dr. Iqbal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Iqbal's full profile

Already have an account?

  • Office

    4500 San Pablo Rd S
    Jacksonville, FL 32224
    Phone+1 904-953-2000

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterResidency, Hematology and Medical Oncology, 2020
  • Fatima Jinnah Medical College
    Fatima Jinnah Medical CollegeClass of 2011
  • Kinnaird College
    Kinnaird CollegeBachelor's, Pre-Medical, 2002 - 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • OK State Medical License
    OK State Medical License 2016 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Second position in Sarcoma Super Bowel 2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • First Report of Hereditary Lysozyme Amyloidosis in a South Asian Family  
    Iqbal, M., Jani, P., Ahmed, S., & Sher, T., Case Reports in Hematology, 1/1/2019
  • Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas  
    Iqbal, M., Roberts, A., Starr, J., Mody, K., & Kasi, P. M., Journal of Gastrointestinal Oncology, 1/1/2019
  • Successful Antimicrobial Treatment of Phlegmonous Gastritis: A Case Report and Literature Review  
    Iqbal, M., Saleem, R., Ahmed, S., Jani, P., Alvarez, S., & Tun, H. W., Case reports in hematology, 1/1/2018
  • Join now to see all

Abstracts/Posters

  • Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Primary Cutaneous T Cell Lymphoma: Results of a Systematic Review/Meta-Analysis.
    Iqbal, M., Reljic, T., Sher, T., Ayala, E., Murthy, H., Roy, V., ... & Kharfan-Dabaja, M. A., Biology of Blood and Marrow Transplantation, 1/1/2019
  • Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Primary Cutaneous T Cell Lymphoma: Results of a Systematic Review/Meta-Analysis
    Madiha Iqbal MD, Tea Reljic , Taimur Sher MD, Ernesto Ayala MD, Hemant Murthy MD, Vivek Roy MD, James Foran MD, Han Tun MD, Ambuj Kumar, Mohamed A. Kharfan-Dabaja MD, TCT annual meeting, Houston, TX, 1/1/2019
  • Assessing the Efficacy of Allogeneic Hematopoietic Cell Transplantation in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.
    Madiha Iqbal MD, Tea Reljic , Taimur Sher MD, Ernesto Ayala MD, Hemant Murthy MD, Ali Bazarbachi MD, Ambuj Kumar MD, Mohamed A. Kharfan-Dabaja MD, Biology of Blood and Marrow Transplantation; TCT annual meeting, Houston, TX, 1/1/2019
  • Join now to see all

Lectures

  • Stem cell transplantation, cellular basis and clinical applications 
    Mayo Clinic - 1/1/2018
  • Approach to Anemia and Peripheral blood disorders 
    Mayo Clinic - 1/1/2018
  • Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML 
    Mayo Clinic - 1/1/2018
  • Join now to see all

Other

  • Feasibility and clinical value of circulating tumor DNA testing in patients with gastroesophageal adenocarcinoma 
    Iqbal, M., Kasi, P. M., & Mody, K., Ascopubs.org
    1/1/2018

Press Mentions

  • What Is CAR-T Cell Therapy? Oncologist Explains
    What Is CAR-T Cell Therapy? Oncologist ExplainsSeptember 29th, 2024
  • ¿Qué Es La Terapia De Células T Con Receptores Quiméricos De Antígenos?
    ¿Qué Es La Terapia De Células T Con Receptores Quiméricos De Antígenos?December 15th, 2022
  • Autologous Transplant or Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Large B-cell Lymphoma: How to Choose?
    Autologous Transplant or Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Large B-cell Lymphoma: How to Choose?December 15th, 2023

Other Languages

  • Hindi, Urdu